A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants
Status:
Recruiting
Trial end date:
2024-12-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine recommended Phase 2 dose (RP2D) regimen(s) of
JNJ-75229414 in Part 1 (Dose Escalation and to determine safety at the RP2D regimen(s) in
Part 2 (Dose Expansion).